Protective effects of ginsenoside F2 on 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation in mice. 2016

Seol-Hee Park, and Wonhyo Seo, and Hyuk Soo Eun, and So Yeon Kim, and Eunjung Jo, and Myung-Ho Kim, and Won-Mook Choi, and Jun-Hee Lee, and Young-Ri Shim, and Chang-Hao Cui, and Sun Chang Kim, and Cheol Yong Hwang, and Won-Il Jeong
The Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.

Topical use of ginsenosides, the major bioactive substances in Panax ginseng, has been used for the treatment of irritated skin complaints. However, the protective mechanisms of ginsenosides remain unclear. In the present study, we investigated the anti-inflammatory role of ginsenoside F2 (GF2) on the skin inflammation. To induce irritant dermatitis, 12-O-tetradecanoylphorbol-13-acetate (TPA) was applied on the surface of the mouse ears with or without treatments of GF2 and dexamethasone for 24 h. Protective effects of GF2 on edema and inflammation were assessed by measuring ear thickness, weights of skin punch, and inflammatory responses. In gross findings, treatments with GF2 significantly decreased skin thickness and weight compared to those of TPA-treated groups, which was comparable with the protective effects of dexamethasone. In addition, expression of inflammatory mediators was remarkably reduced in GF2-treated ears compared to that of vehicle-treated ears of mice. Interestingly, immunohistochemistry and flow cytometry analyses revealed that TPA treatment significantly increased infiltration of interleukin-17 (IL-17) producing dermal γδ T cells, while frequencies of γδ T cells was decreased by GF2 treatment, subsequently ameliorating inflammation in skin. Concomitantly, TPA-mediated skin inflammation was significantly ameliorated in IL-17A knock out mice. Furthermore, GF2 treatment inhibited infiltration and generation of reactive oxygen species (ROS) of neutrophils in damaged ears compared with vehicle-treated mice. These results clearly suggest that GF2 treatment ameliorates TPA-induced dermal inflammation by inhibiting production of IL-17 and ROS in γδ T cells and neutrophils, respectively. Therefore, as a natural compound, application of GF2 may be a novel therapeutic approach for treating skin inflammation.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D003872 Dermatitis Any inflammation of the skin. Dermatitides
D004431 Ear, External The outer part of the hearing system of the body. It includes the shell-like EAR AURICLE which collects sound, and the EXTERNAL EAR CANAL, the TYMPANIC MEMBRANE, and the EXTERNAL EAR CARTILAGES. External Ear,Outer Ear,Ear, Outer,Ears, External,Ears, Outer,External Ears,Outer Ears
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

Seol-Hee Park, and Wonhyo Seo, and Hyuk Soo Eun, and So Yeon Kim, and Eunjung Jo, and Myung-Ho Kim, and Won-Mook Choi, and Jun-Hee Lee, and Young-Ri Shim, and Chang-Hao Cui, and Sun Chang Kim, and Cheol Yong Hwang, and Won-Il Jeong
September 2018, Chronobiology international,
Seol-Hee Park, and Wonhyo Seo, and Hyuk Soo Eun, and So Yeon Kim, and Eunjung Jo, and Myung-Ho Kim, and Won-Mook Choi, and Jun-Hee Lee, and Young-Ri Shim, and Chang-Hao Cui, and Sun Chang Kim, and Cheol Yong Hwang, and Won-Il Jeong
September 2019, European journal of pharmacology,
Seol-Hee Park, and Wonhyo Seo, and Hyuk Soo Eun, and So Yeon Kim, and Eunjung Jo, and Myung-Ho Kim, and Won-Mook Choi, and Jun-Hee Lee, and Young-Ri Shim, and Chang-Hao Cui, and Sun Chang Kim, and Cheol Yong Hwang, and Won-Il Jeong
January 1991, Skin pharmacology : the official journal of the Skin Pharmacology Society,
Seol-Hee Park, and Wonhyo Seo, and Hyuk Soo Eun, and So Yeon Kim, and Eunjung Jo, and Myung-Ho Kim, and Won-Mook Choi, and Jun-Hee Lee, and Young-Ri Shim, and Chang-Hao Cui, and Sun Chang Kim, and Cheol Yong Hwang, and Won-Il Jeong
April 1989, Chemical & pharmaceutical bulletin,
Seol-Hee Park, and Wonhyo Seo, and Hyuk Soo Eun, and So Yeon Kim, and Eunjung Jo, and Myung-Ho Kim, and Won-Mook Choi, and Jun-Hee Lee, and Young-Ri Shim, and Chang-Hao Cui, and Sun Chang Kim, and Cheol Yong Hwang, and Won-Il Jeong
June 2012, BMB reports,
Seol-Hee Park, and Wonhyo Seo, and Hyuk Soo Eun, and So Yeon Kim, and Eunjung Jo, and Myung-Ho Kim, and Won-Mook Choi, and Jun-Hee Lee, and Young-Ri Shim, and Chang-Hao Cui, and Sun Chang Kim, and Cheol Yong Hwang, and Won-Il Jeong
May 2016, International immunopharmacology,
Seol-Hee Park, and Wonhyo Seo, and Hyuk Soo Eun, and So Yeon Kim, and Eunjung Jo, and Myung-Ho Kim, and Won-Mook Choi, and Jun-Hee Lee, and Young-Ri Shim, and Chang-Hao Cui, and Sun Chang Kim, and Cheol Yong Hwang, and Won-Il Jeong
November 2013, Journal of agricultural and food chemistry,
Seol-Hee Park, and Wonhyo Seo, and Hyuk Soo Eun, and So Yeon Kim, and Eunjung Jo, and Myung-Ho Kim, and Won-Mook Choi, and Jun-Hee Lee, and Young-Ri Shim, and Chang-Hao Cui, and Sun Chang Kim, and Cheol Yong Hwang, and Won-Il Jeong
February 2020, Mycoses,
Seol-Hee Park, and Wonhyo Seo, and Hyuk Soo Eun, and So Yeon Kim, and Eunjung Jo, and Myung-Ho Kim, and Won-Mook Choi, and Jun-Hee Lee, and Young-Ri Shim, and Chang-Hao Cui, and Sun Chang Kim, and Cheol Yong Hwang, and Won-Il Jeong
August 2013, The Journal of pharmacy and pharmacology,
Seol-Hee Park, and Wonhyo Seo, and Hyuk Soo Eun, and So Yeon Kim, and Eunjung Jo, and Myung-Ho Kim, and Won-Mook Choi, and Jun-Hee Lee, and Young-Ri Shim, and Chang-Hao Cui, and Sun Chang Kim, and Cheol Yong Hwang, and Won-Il Jeong
February 2006, Planta medica,
Copied contents to your clipboard!